110 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
to integrate our newly acquired aPKCi inhibitor into our preclinical portfolio, which we believe has an exciting preclinical data package with two
424B4
WINT
Windtree Therapeutics Inc
20 Apr 23
Prospectus supplement with pricing info
6:03pm
package inserts also may arise.
We presently carry comprehensive general liability, property damage, product liability, workers’ compensation, health
424B4
jnc7 1iy9ppsm703n
21 May 20
Prospectus supplement with pricing info
6:04am